A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Type 2 Diabetes
Related studies linked through entity extraction aliases.
Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Antioxidant Treatment of Type 2 Diabetes
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia
- Status
- COMPLETED
- Phase
- NA
U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod
- Status
- COMPLETED
- Phase
- PHASE4
Role of Pancreatic Triglyceride Content in Beta-cell Function
- Status
- COMPLETED
- Phase
- N/A
Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Pilot Study to Assess Pre-packaged, Portion-controlled Meal Plan on Weight Loss
- Status
- COMPLETED
- Phase
- NA
Effects of Medical and Surgical Weight Loss on Metabolism
- Status
- COMPLETED
- Phase
- N/A
Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Genetic Variation in OCT1 and Response to Metformin
- Status
- WITHDRAWN
- Phase
- PHASE4
Effect of Discontinuation of Sugar Sweetened Beverages
- Status
- COMPLETED
- Phase
- NA
Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
- Status
- TERMINATED
- Phase
- N/A
Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
- Status
- COMPLETED
- Phase
- PHASE3
Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period
- Status
- COMPLETED
- Phase
- PHASE3
Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Characteristics of Glargine in Type 2 Diabetics
- Status
- COMPLETED
- Phase
- PHASE1
Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 1
- Status
- COMPLETED
- Phase
- NA